Strobilanthes crispus Juice Concentrations and Anticancer Effects on DNA Damage, Apoptosis and Gene Expression in Hepatocellular Carcinoma Cells

  • Hussin, Faridah (Faculty of Medicine and Health Sciences, Universiti Putra Malaysia) ;
  • Eshkoor, Sima Ataollahi (Institute of Gerontology, Universiti Putra Malaysia) ;
  • Rahmat, Asmah (Faculty of Medicine and Health Sciences, Universiti Putra Malaysia) ;
  • Othman, Fauziah (Faculty of Medicine and Health Sciences, Universiti Putra Malaysia) ;
  • Akim, Abdah (Faculty of Medicine and Health Sciences, Universiti Putra Malaysia) ;
  • Eshak, Zolkapli (Faculty of Pharmacy, Universiti Teknologi MARA)
  • Published : 2015.09.02


Background: Hepatocellular carcinoma is one of the most common cancers worldwide. Its prevalence is increasing in many countries. Plant products can be used to protect against cancer due to natural anticancer and chemopreventive constituents. Strobilanthes crispus is one of plants with potential chemopreventive ability. Objective: This study aimed to evaluate the anticancer effects of Strobilanthes crispus juice on hepatocellular carcinoma cells. Materials and Methods: MTT assays, flow cytometry, comet assays and the reverse transcription-polymerase chain reaction (RT-PCR) were used to determine the effects of juice on DNA damage and cancer cell numbers. Results: This juice induced apoptosis after exposure of the HepG2 cell line for 72 h. High percentages of apoptotic cell death and DNA damage were seen at the juice concentrations above 0.1%. It was found that the juice was not toxic for normal cells. In addition, juice exposure increased the expression level of c-myc gene and reduced the expression level of c-fos and c-erbB2 genes in HepG2 cells. The cytotoxic effects of juice on abnormal cells were in dose dependent. Conclusions: It was concluded that the Strobilanthes crispus juice may have chemopreventive effects on hepatocellular carcinoma cells.


  1. Abdelaziz AO, Elbaz TM, Shousha HI, et al (2014). Survival and prognostic factors for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Asian Pac J Cancer Prev, 15, 3915-20.
  2. Amati B, Frank SR, Donjerkovic D, et al (2001). Function of the c-myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta, 1471, 135-45.
  3. Awad A, Downie A, Fink C (2000). Inhibition of growth and stimulation of apoptosis by beta-sitosterol treatment of MDA-MB-231 human breast cancer cells in culture. Intl J Molecular Med, 5, 541.
  4. Awad AB, Fink CS (2000). Phytosterols as anticancer dietary components:evidence and mechanism of action. J Nutrit, 130, 2127-30.
  5. Cai Y, Lua Q, Sun M, et al (2000). Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci, 74, 2157-84.
  6. Chong HZ, Rahmat A, Yeap SK, et al (2012). In vitro cytotoxicity of Strobilanthes crispus ethanol extract on hormone dependent human breast adenocarcinoma MCF-7 cell. BMC Complem Alternat Med, 12, 35.
  7. Coucouvanis EC, Jones PP (1993). Changes in protooncogene expression correlated with general and sex specific differentiation in murino primordial germ cells. Mech Dev, 42, 49-58.
  8. Dani C, Vestri V, Bertini G, et al (2007). Toxicity of corticosteroids and catecholamines for mice neuronal cell cultures: Role of preservatives. J Maternal-Fetal Neonatal Med, 20, 325-33.
  9. Dong JM, Naito Y, Tsuruo T (1997). C-myc play a role in cellular susceptibility to death receptor-mediated and chemotherapyinduced apoptosis in human monocytic leukemia U937 cells. Oncogene, 15, 639-47.
  10. Eisenberg DM, Davis RB, Ettner SL (1998). Trends in alternative medicine use in the United States, 1990-1997. JAMA, 280, 1569-75.
  11. Eshkoor SA, Ismail P, Abd.Rahman S, et al (2012). The Association of DNA Damage Level with Early Age at the Occupational Exposure in the Mechanical Workshops Workers. Asian J Biotechnol, 4, 83-91.
  12. Firenzuoli F, Gori L (2007). Herbal medicine today: Clinical and Research Issues. eCAM, 4, 37-40.
  13. Geran R (1972). Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep, 3, 51-61.
  14. Hamilton SR, Aaltonen LA (2004). Pathology and genetics: tumors of the digestive system. Lyon: IARC; 2000. 1010 C. Alexia et al. Biochemical Pharmacol, 68, 1003-15.
  15. Hu L, Hatano M, Ruther U, et al (1996). Overexpression of c-Fos induces apoptosis of CD43+ pro-B cells. J Immunol, 157, 3804-11.
  16. Inada K, Okada S, Phuchareon J, et al (1998). C-Fos Induces Apoptosis in Germinal Center B Cells. J Immunol, 161, 3853-61.
  17. Ju EM, Lee SE, Hwang HJ, et al (2004). Antioxidant and anticancer activity of extract from Betula platyphylla var. japonica. Life scien 74, 1013-26.
  18. Kalra N, Kumar V (2004). C-fos is a mediator of the c-mycinduced appoptitic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J Biological Chem, 279, 25313-9.
  19. Kaur M, Agarwal C, Agarwal R (2009). Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J Nutrit 139, 1806-12.
  20. Kazi A, Urbizu DA, Kuhn DJ, et al (2003). A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells. International J Molecular Medicine, 12, 879-88.
  21. Kimman M, Norman R, Jan S, et al (2012). The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev, 13, 411-20.
  22. Kovary K, Bravo R (1991). The c-jun and c-fos protein families are both required for cell cycle progression in fibroblast. Molecular Cell Biol, 11, 4466-72.
  23. Kumar V, Fausto N, Abbas A (2003). Robbins & Cotran Pathologic Basis of Disease, 7th, Saunders. 914-7.
  24. Kusumoto JT, Shimada I, Kakiuchi N, et al (1992). Inhibitory effects of Indonesian plant extracts on reverse trancriptase of an RNA tumour virus (I). Phytotheraphy Res, 6, 241-4.
  25. Landay M, Oster SK, Khosravi F, et al (2000). Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family. Cell Death Differ, 7, 697-705.
  26. Li D, Tonya M, Shinji S (2001). AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clinica chemica acta, 313, 15-9.
  27. Li SS, Gao Z, Feng X, et al (2004). Plant sterols as selective DNA polymerase beta lyase inhibitors and potentiators of bleomycin cytotoxicity. Bioorganic Med Chem, 12, 4253-8.
  28. Liu M, Jiang L, Guan X-Y (2014). The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell, 5, 673-91.
  29. Magiatis P, Pratsinis H, Kalpoutzakis E, et al (2001). Hydrolyzable tannins, the active constituents of three Greek Cytinus taxa against several tumor cell lines. Biological Pharmaceutical Bulletin, 24, 707-9.
  30. McKelvey-Martin VJ, Green MHL, Schmezer P, et al (1993). The single cell gel electro (comet assay): A European review. Mutat. Res, 288, 47-63.
  31. Moongkarndi P, Kosem N, Kaslungka S, et al (2004). Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J ethnopharmacol, 90, 161-6.
  32. Nicoletti I, Migliorati G, Pagliacci MC, et al (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunological Methods, 139, 271-9.
  33. Nilsson JA, Maclean KH, Keller UB, et al (2004). Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Molecular Cellular Biol, 24, 1560-9.
  34. Normen AL, Brants HA, Voorrips LE, et al (2001). Plant sterol intakes and colorectal cancer risk in the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutrit, 74, 141-8.
  35. Obata S, Okada S, Ohkubo Y, et al (2003). Over expression of the c-fos gene perturbs functional maturation of MI cells into macrophages. Molecular immunol, 39, 585-94.
  36. Oliveria SA (1997). The Role of Epidemiology in Cancer Prevention. Soc Exp Bio Med, 216, 142-50.
  37. Omar ZA, Ali ZM, Tamin NSI (2006). Malaysian cancer statistics - data and figureure peninsular Malaysia
  38. Park YK, Park E, Kim JS, Kang MH (2003). Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Koreans. Mutat Res, 529, 77-86.
  39. Pedrosa R, Soares-da-Silva P (2002). Oxidative and nonoxidative mechanisms of neuronal cell death and apoptosis by L-3, 4-dihydroxyphenylalanine (L-DOPA) and dopamine. British J Pharmacol, 137, 1305-13.
  40. Pitot HC (1998). Hepatocyte death in hepatocarcinogenesis. Hepatol, 28, 1-5.
  41. Robson S, Ward L, Brown H, et al (2011). Deciphering c-MYCregulated genes in two distinct tissues. BMC genomics, 12, 476.
  42. Scott G, Dodson J, Montgomery P, et al (1991). p185HER2 signal transduction in breast cancer cells. J Biological Chem, 266, 14300-5.
  43. Singh S, Singh PP, Roberts LR, et al (2014). Chemopreventive strategies in hepatocellular carcinoma. Nature Reviews Gastroenterol Hepatol, 11, 45-54.
  44. Sunarto PA (1997). Material medika indonesia. 1st ed. Pp. 95- 99. Jakarta: penerbit direktorat jenderal pengawasan obat dan makanan.
  45. Tannapfel A, Wittekind C (2002). Genes involved in hepatocellular carcinoma:deregulation in cell cycling and apoptosis. Virchows Arch, 440, 345-52.
  46. Tesarika J, Garrigosa L, Mendoza C (1999). Estradiol modulates breast cancer cell apoptosis: a novel nongenomic steroid action relevant to carcinogenesis. Steroids, 64, 22-7.
  47. Thompson EB (1998). The many roles of c-Myc in apoptosis. Annual Review Physiol, 60, 575-600.
  48. Thorgeirsson SS, Teramoto T, Factor VM (1998). Dysregulation of apoptosis in hepatocellular carcinoma. Seminar Liver Dis, 18, 115-22.
  49. Tiberio L, Maier JAM, Schiaffonati L (2001). Down-modulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apotosis: role of ornithine decarboxlase and polyamines. Cell Death Differentiat, 8, 967-76.
  50. Vega-Avila E, Pugsley MK ( 2011). An Overview of Colorimetric Assay Methods Used to Assess Survival or Proliferation of Mammalian Cells. Proc West Pharmacol Soc, 54, 10-4.
  51. Volm M, Efferth T, Mattern J (1992). Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res, 12, 11.
  52. Yu D, Hung MC (2000). Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene, 19, 6115-21.